Hepatitis C virus (HCV) genotypes and the influence of HCV subtype 1b on the progression of chronic hepatitis C in Korea: a single center experience
1
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Background/Aims: The re is some controversy regarding whether or not hepatitis C virus (HCV) subtype 1b is more infl uential than non-1b subtypes on the progression of chronic hepatitis (CH) C to liver cirrhosis (LC) and hepatocellular carcinoma (HCC). Methods: We retrospectively analyzed 823 patients with chronic HCV infection, including 443 CH patients, 264 LC patients, and 116 HCC patients, who were HCV RNA positive and HBsAg negative. These patients had not received any prior treatment with either interferon alone or a combination of interferon and ribavirin. Results: HCV subtypes 1b (51.6%) and 2a/2c (39.5%) were the two most common genotypes. The proportions of genotypes 2 (2a/2c, 2b, and 2) and 3 were 45.8% and 1.1%, respectively. One case of genotype 4 was found. HCV subtype 1b (47.3%) was less common than the non-1b subtypes (52.7%) in non-LC patients, but its proportion (56.9%) was higher than that of non-1b subtypes (43.1%) in LC patients (P=0.006). The proportions of patients with HCV subtype 1b did not diff er signifi cantly between the LC (55.3%) and HCC (60.3%) groups. Older age, male gender, and the relative progression of liver damage (non-LC vs. compensated LC vs. decompensated LC) were significant risk factors for HCC, with odds ratios of 1.081 (95% confi dence interval [CI], 1.056-1.106), 5.749 (95% CI, 3.329-9.930), and 2.895 (95% CI, 2.183-3.840),respectively. HCV subtype 1b was not a signifi cant risk factor for HCC (odds ratio, 1.423; 95% CI, 0.895-2.262). Conclusions: HCV subtypes 1b and 2a/2c were the two most common HCV genotypes. HCV subtype 1b seemed to be more infl uential than non-1b subtypes on the progression of CH to LC, but not on the development of HCC from LC. (Clin Mol Hepatol 2012;18:219-224)
Abstract
Background/Aims: The re is some controversy regarding whether or not hepatitis C virus (HCV) subtype 1b is more infl uential than non-1b subtypes on the progression of chronic hepatitis (CH) C to liver cirrhosis (LC) and hepatocellular carcinoma (HCC). Methods: We retrospectively analyzed 823 patients with chronic HCV infection, including 443 CH patients, 264 LC patients, and 116 HCC patients, who were HCV RNA positive and HBsAg negative. These patients had not received any prior treatment with either interferon alone or a combination of interferon and ribavirin. Results: HCV subtypes 1b (51.6%) and 2a/2c (39.5%) were the two most common genotypes. The proportions of genotypes 2 (2a/2c, 2b, and 2) and 3 were 45.8% and 1.1%, respectively. One case of genotype 4 was found. HCV subtype 1b (47.3%) was less common than the non-1b subtypes (52.7%) in non-LC patients, but its proportion (56.9%) was higher than that of non-1b subtypes (43.1%) in LC patients (P=0.006). The proportions of patients with HCV subtype 1b did not diff er signifi cantly between the LC (55.3%) and HCC (60.3%) groups. Older age, male gender, and the relative progression of liver damage (non-LC vs. compensated LC vs. decompensated LC) were significant risk factors for HCC, with odds ratios of 1.081 (95% confi dence interval [CI], 1.056-1.106), 5.749 (95% CI, 3.329-9.930), and 2.895 (95% CI, 2.183-3.840),respectively. HCV subtype 1b was not a signifi cant risk factor for HCC (odds ratio, 1.423; 95% CI, 0.895-2.262). Conclusions: HCV subtypes 1b and 2a/2c were the two most common HCV genotypes. HCV subtype 1b seemed to be more infl uential than non-1b subtypes on the progression of CH to LC, but not on the development of HCC from LC. (Clin Mol Hepatol 2012;18:219-224)
참고문헌 (30)
- YoungSunKim, "The Prognosis of Liver Cirrhosis in Recent Years in Korea", Journal of Korean Medical Science, 18(6), pp.833~841 (2003), 대한의학회
- Lee HS, "Predominant etiologic association of hepatitis C virus with hepatocellular carcinoma compared with hepatitis B virus in elderly patients in a hepatitis B-endemic area", Cancer, 72, pp.2564~2567 (1993)
- Stuyver L, "Second-generation line probe assay for hepatitis C virus genotyping", J Clin Microbiol, 34, pp.2259~2266 (1996)
- Zein NN, "Clinical significance of hepatitis C virus genotypes", Clin Microbiol Rev, 13, pp.223~235 (2000)
- Kamal SM, "Hepatitis C genotype 4: What we know and what we don’t yet know", Hepatology, 47, pp.1371~1383 (2008)
- Davidson F, "Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5’ non-coding region", J Gen Virol, 76, pp.1197~1204 (1995)
- Pawlotsky JM, "Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C", J Infect Dis, 171, pp.1607~1610 (1995)
- Shin HR, "Epidemiology of hepatitis C virus in Korea", Intervirology, 49, pp.18~22 (2006)
- Nousbaum JB, "Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group", Ann Intern Med, 122, pp.161~168 (1995)
- López-Labrador FX, "Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma", J Hepatol, 27, pp.959~965 (1997)
- Lee CM, "Viral etiology of hepatocellular carcinoma and HCV genotypes in Taiwan", Intervirology, 49, pp.76~81 (2006)
- Ikeda K, "Influence of hepatitis C virus subtype on hepatocellular carcinogenesis: a multivariate analysis of a retrospective cohort of 593 patients with cirrhosis", Intervirology, 45, pp.71~78 (2002)
- Bruno S, "Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study", Hepatology, 25, pp.754~758 (1997)
- Silini E, "Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study", Gastroenterology, 111, pp.199~205 (1996)
- McHutchison JG, "Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group", N Engl J Med, 339, pp.1485~1492 (1998)
- 최준호, "Hepatitis C virus genotypes in Korea and their relationship to clinical outcome in type C chronic liver diseases.", The Korean journal of internal medicine, 12(1), pp.21~27, Korean Association of Internal Medicine
- Mangia A, "HCV genotypes in patients with liver disease of different stages and severity", J Hepatol, 26, pp.1173~1178 (1997)
- 이호준, "제주 지역 만성 C형간질환 환자의 유전자형의 분포", Clinical and Molecular Hepatology, 14(1), pp.28~35 (2008), 대한간학회
- Bruno S, "Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study", Hepatology, 25, pp.754~758 (1997)
- Yotsuyanagi H, "Hepatitis C virus genotypes and development of hepatocellular carcinoma", Cancer, 76, pp.1352~1355 (1995)
- Pugh RN, "Transection of the oesophagus for bleeding oesophageal varices", Br J Surg, 60, pp.646~649 (1973)
- Tchelepi H, "Sonography of diffuse liver disease", J Ultrasound Med, 21, pp.1023~1034 (2002)
- Marrero JA, "Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass", Liver Transpl, 11, pp.281~289 (2005)
- Bruix J, "Management of hepatocellular carcinoma", Hepatology, 42, pp.1208~1236 (2005)
- Zein NN, "Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group", Ann Intern Med, 125, pp.634~639 (1996)
- Berg T, "Distribution of hepatitis C virus genotypes in German patients with chronic hepatitis C: correlation with clinical and virological parameters", J Hepatol, 26, pp.484~491 (1997)
- Isobe K, "Hepatitis C virus infection and genotypes in Japanese hemophiliacs", Liver, 15, pp.131~134 (1995)
- Krug LP, "Hepatitis C virus genotypes in Southern Brazil", Braz J Med Biol Res, 29, pp.1629~1632 (1996)
- Raghuraman S, "Distribution of the different genotypes of HCV among patients attending a tertiary care hospital in south India", J Clin Virol, 26, pp.61~69 (2003)
- El-Serag HB, "Hepatocellular carcinoma: epidemiology and molecular carcinogenesis", Gastroenterology, 132, pp.2557~2576 (2007)